Adagio medical reports fourth quarter and full year 2024 results

Laguna hills, calif.--(business wire)--adagio medical holdings, inc. (nasdaq: adgm), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today reported financial results for the fourth quarter and full year ended december 31, 2024. recent business highlights: reported total company revenue of $137 thousand in the fourth quarter of 2024, compared to $78 thousand in the fourth quarter of 2023. full year revenue for 2024 was $0.6 million compared to $0.3.
ADGM Ratings Summary
ADGM Quant Ranking